GlassScriptPhysician profile
Michael L Brasel
NPI 1184047904
$548.63
in general payments reported to CMS, 2019-2025
11 companies · $72.23 in 2025
The $72.23 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2023: $268 · 2024: $99.55 · 2025: $72.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $113.27 | 2024-2025 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $89.03 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Mylan Specialty L.P. | $69.91 | 2023 | Yupelri |
| Merck Sharp & Dohme LLC | $58.02 | 2023 | Verquvo, Belsomra |
| Welch Allyn | $52.60 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $38.70 | 2023 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $38.00 | 2023-2024 | Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $32.72 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.15 | 2021 | |
| Genentech USA, INC. | $15.12 | 2021 | |
| Lilly USA, LLC | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brasel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.